Patient Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$6.91M |
| 2 |
Cleveland-Cliffs
CLF
|
+$6.74M |
| 3 |
Citigroup
C
|
+$6.42M |
| 4 |
Peloton Interactive
PTON
|
+$4.19M |
| 5 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$3.45M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Diamondback Energy
FANG
|
+$5.23M |
| 2 |
Bank of America
BAC
|
+$2.84M |
| 3 |
TVTY
Tivity Health, Inc. Common Stock
TVTY
|
+$2.51M |
| 4 |
AVID
Avid Technology Inc
AVID
|
+$2.04M |
| 5 |
The RealReal
REAL
|
+$2.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 22.57% |
| 2 | Technology | 11.12% |
| 3 | Financials | 9.83% |
| 4 | Healthcare | 9% |
| 5 | Energy | 8.76% |
Similar funds
Patient Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, Patient Capital Management held 50 positions worth $295M, down 15% from $347M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Patient Capital Management withdrew a net $36.2M in Q1 2022, closing 5 positions and reducing 21 holdings. Its most notable exit was The RealReal, an estimated $2.01M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 23% of assets, up from 18% a quarter earlier, followed by Technology and Financials.
Against the trend, Patient Capital Management opened a new position in Cleveland-Cliffs worth $9.52M.
- Patient Capital Management's largest Q1 2022 buy was Cleveland-Cliffs: 295,700 shares worth $9.52M.
- Patient Capital Management added most to Amazon in Q1 2022, an estimated $6.91M increase.
- Patient Capital Management's biggest Q1 2022 reduction was Diamondback Energy, cutting an estimated $5.23M.
- Patient Capital Management fully exited The RealReal in Q1 2022, selling an estimated $2.01M.
- Patient Capital Management's ten largest holdings make up 43% of its $295M portfolio in Q1 2022.
- Patient Capital Management opened 7 new positions and closed 5 in Q1 2022.
- Patient Capital Management's portfolio value fell 15% quarter-over-quarter to $295M.
Based on Patient Capital Management's 13F filing for Q1 2022, filed 16 May 2022.